Designer dendritic cells for tolerance induction: Guided not misguided missiles

Trends in Immunology

Volumn 22, Issue 8, 2001, Pages 437-442

  Hackstein, Holger ^a   Morelli, Adrian E ^a   Thomson, Angus W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; TUMOR ANTIGEN; VACCINE;

ADOPTIVE IMMUNOTHERAPY; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL CULTURE; DENDRITIC CELL; EMBRYO CELL; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; NONHUMAN; REVIEW; STEM CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION;

EID: 0035425422     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)01959-7     Document Type: Review

References (52)

1. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo
2. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
3. Immunobiology of dendritic cells
4. Natural adjuvants: Endogenous activators of dendritic cells
5. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
6. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T-cell areas of mesenteric lymph nodes
7. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity
8. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin-10 and induce the differentiation of T helper type 2 cells
9. Effects of liver-derived dendritic-cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo
10. + T-cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
11. + T cells
12. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
13. Antigen-specific inhibition of effector T-cell function in humans after injection of immature dendritic cells
14. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells
15. Aspirin inhibits the in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells
16. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells
17. Contrasting effects of TGF-β1 and TNF-α on the development of dendritic cells from progenitors in mouse bone marrow
18. Induction of tolerance by IL-10-treated dendritic cells
19. 1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T-cell activation
20. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
21. Dendritic-cell survival and maturation are regulated by different signaling pathways
22. The NF-κB and IκB proteins: New discoveries and insights
23. Prolongation of cardiac allograft survival using dendritic cells treated with NF-κB decoy oligodeoxyribonucleotides
24. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness
25. Feasibility of CTLA-4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T-cell anergy in vitro
26. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGF-β and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2
27. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells
28. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
29. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo
30. -) prolong cardiac allograft survival in nonimmunosuppressed recipients
31. Granulocyte- macrophage colony-stimulating factor-stimulated hepatic dendritic-cell progenitors prolong pancreatic islet allograft survival
32. A dendritic-cell line genetically modified to express CTLA-4Ig as a means to prolong islet allograft survival
33. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats
34. Immunotherapy of NOD mice with bone marrow-derived dendritic cells
35. Transfer of dendritic cells (DC) ex vivo stimulated with interferon γ (IFN-γ) downmodulates autoimmune diabetes in nonobese diabetic (NOD) mice
36. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4
37. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells
38. - (myeloid) dendritic cells differentially regulate vascularized organ allograft survival
39. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic-cell progenitors to induce long-term cardiac allograft survival
40. Prolonged skin allograft survival in mice treated with Flt3 ligand-induced dendritic cells and anti-CD154 monoclonal antibody
41. Microchimerism, donor dendritic cells and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: Modulation by tacrolimus
42. Direct and indirect recognition: The role of MHC antigens in graft rejection
43. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway
44. + T cells
45. Notch signaling: Cell-fate control and signal integration in development
46. Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells
47. Expanding dendritic cells in vivo enhances the induction of oral tolerance
48. Blockade of T-cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152)
49. Directed differentiation of dendritic cells from mouse embryonic stem cells
50. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibits IL-2 production and proliferation
51. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T-cell apoptosis
52. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells